文献速递临床试验与 GCP流行病学与生物统计

低FODMAP饮食对溃疡性结肠炎患者肠道微生物组和炎症影响的随机对照试验:研究方案

A randomized controlled trial investigating the effect of a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols on the intestinal microbiome and inflammation in patients with ulcerative colitis: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2020-02-18

主要探索低FODMAP饮食对肠道微生物群、炎症标志物及临床症状的影响。研究已注册(IRCT20181126041763N1)。

要点

  • 低FODMAP饮食可能减轻溃疡性结肠炎患者的肠道和全身炎症。
  • 结局包括特定肠道菌群、粪便钙卫蛋白和乳铁蛋白、血清hs-CRP、TNF-α和IL-1β。

核心结论

  • 低FODMAP饮食可能降低溃疡性结肠炎患者的系统性和肠道炎症,改变肠道细菌种群并调节临床症状。

关键数值与推荐

  • 检测粪便中梭菌簇IV、Faecalibacterium prausnitzii、Rosburia spp.、Lactobacillus spp.、Bifidobacteria spp.、Akkermansia muciniphila、Bacteroides fragilis、Ruminococcus spp.的数量及厚壁菌门与拟杆菌门比值。
  • 检测粪便钙卫蛋白和乳铁蛋白水平。
  • 检测血清hs-CRP、TNF-α和IL-1β浓度。

局限性

  • 需要进一步研究低FODMAP饮食对其他变量(包括其他细菌种类和炎症细胞因子)的影响以证实本试验的未来发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: No conclusive treatment is available for irritable bowel disease (IBD). Adherence to a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) might alleviate clinical symptoms of IBD. However, no study has investigated the effect of low FODMAPs diet on the intestinal microbiota and inflammatory biomarkers in patients with IBD. The aim of current study is to examine the effect a low FODMAP diet on IBD symptoms, inflammation, and the intestinal microbiota in patients with ulcerative colitis. METHODS AND ANALYSIS: This study is a randomized clinical trial. Thirty patients with mild to moderate ulcerative colitis will be randomly allocated to receive a low FODMAP diet (n = 15) or to continue their usual diet as control (n = 15), for 4 weeks. The quantity of intestinal microbiota including Clostridium cluster IV, Faecalibacterium prausnitzii, Rosburia spp., Lactobacillus spp., Bifidobacteria spp., Akkermansia muciniphila, Bacteroides fragilis, and Ruminococcus spp., and the Firmicutes to Bacteroidetes ratio and calprotectin and lactoferrin levels will be explored in fecal samples from patients. In addition, anthropometric measures and biochemical assessments including serum concentrations of highly sensitive-C reactive protein (hs-CRP), tumour necrosis factor-α (TNF-α) and IL-1β will be taken from patients at baseline and end of the study. The study has been registered in IRCT (IRCT20181126041763N1; registration date: 2019-01-18). DISCUSSION: Consumption of a low-FODMAP diet might decrease systemic and intestinal inflammation, change the bacterial population in the gut, and modulate clinical symptoms in patients with ulcerative colitis. Further studies investigating the effect of such a diet on other variables, including other bacterial species and inflammatory cytokines, are required to confirm future findings of this trial.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Milajerdi A, Sadeghi O, Siadat SD, et al. A randomized controlled trial investigating the effect of a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols on the intestinal microbiome and inflammation in patients with ulcerative colitis: study protocol for a randomized controlled trial. Trials. 2020. PMID: 32070388. doi:10.1186/s13063-020-4108-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。